Nucleophosmin and P27 immunohistochemical markers expression in acute myeloid leukemia

  • سال انتشار: 1394
  • محل انتشار: هفدهمین همایش سالانه آسیب شناسی و طب آزمایشگاه
  • کد COI اختصاصی: ACPLMED17_114
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 504
دانلود فایل این مقاله

نویسندگان

Mohammad Hadi Sadeghian

Department of Hematology and Blood Bank, Cancer Molecular Pathology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Mohammad Hadi Sadeghian

Department of Hematology and Blood Bank, Cancer Molecular Pathology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Amir Hossein Jaffarian

Department of Hematology and Blood Bank, Cancer Molecular Pathology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Hossein Ayatollahi

Department of Hematology and Blood Bank, Cancer Molecular Pathology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

چکیده

Background: Significant improvements have been done in identification of pathogenesis and prognostic factors in acute leukemia. There is not enough documents for nucleophosmin 1(NPM1) as independent prognostic and therapeutic factor in these patients. Acute myeloid leukemia with this genetic mutation is a distinct entity in WHO 2008 classification of acute myeloid leukemia. P27 mutation correlates with disease free survival (DFS) in acute myeloid leukemia. In this study, we evaluate NPM1 and P27 mutation frequencies and consider their relation with clinical and laboratory markers.Materials and methods: In this retrospective study, we chose 30 bone marrow biopsies with distinct diagnosis of acute myeloid leukemia in Qhaem department of pathology from 1389 to 1392. Bone marrow sections were stained with NPM1 and P27 markers. We evaluated clinical and laboratory data of patients and followed them as death event for 1 year.Results: 60% of patients were male and 40% of them were female. Mean age was 36.53 + 18.5. NPM1 and P27 were detected in 9(29%) and 7(23%) patients respectively. Mean survival of patients with NPM1 and P27 were 9and 10 months respectively. There was significant difference between leukocytosis with NPM1 (P=0.010) and P27 mutations (P=0.033).Conclusions: White blood cells count was higher in patients with nucleophosmin 1 and P27 mutations than patients without these mutations . Specific treatment modalities in acute myeloid leukemia may have been developed , based on clinical and laboratory charactristics of these mutations .

کلیدواژه ها

Acute myeloid leukemia, Nucleophosmin 1, P27

مقالات مرتبط جدید

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.